Secondary objectives include the analysis of the relationship between the cognitive deficit and psychopathological status and, in a subgroup of patients, the evaluation of the effect of SREBF1 rs11868035 genetic polymorphism on both cognitive functioning and MetS. This evidence concerns the gene SREBF1 and Cognitive impairment.